Norfloxacin, a nalidixic acid analogue, inhibited streptolysin S (SLS) production when added to young streptococcal culture. D N A synthesis was mainly affected, but increm ent o f cell mass, R N A and protein was also significantly reduced in streptococci treated with norfloxacin. In stationary phase cells and in the w ashed resting bacteria, the toxin production was resistant to the drug. Pretreatm ent with norfloxacin did not abolish the cellular capacity to produce SLS. A l though extracellular SLS was detectable at log phase of streptococcal growth, enhanced produc tion of the toxin occurred upon cessation o f coccal multiplication. In contrast to norfloxacin, lower concentration of rifampicin inhibited SLS production, even added at late log or early stationary phase. Roles o f growth phase, m edium and carrier in induction of SLS production were analyzed as well.
Introduction
Streptococcal growth and SLS production are not affected by nalidixic acid [1] , an inhibitor of D NA gyrase. The toxin production, which requires certain carrier substance such as RNA [2] or detergent [3] , is insensitive to novobiocin as well [1] , and possible role of D N A gyrase in SLS m essenger R N A syn thesis remains to be elucidated. Norfloxacin (AM-715), an analogue of nalidixic acid recently syn thesized in the laboratory of Kyorin Pharm aceutical Co. L td., inhibits growth of various bacteria in cluding Streptococcus pyogenes [4] . A lthough this com pound (l-ethyl-6-fluoro-l,4-dihydro-4-oxo-7-(lpiperazinyl)-3-quinolinecarboxylic acid) rather pref erentially inhibits D N A synthesis in E. coli [5] , its effect has not been tested on m acrom olecular syn thesis in Gram-positive bacteria.
RNA (or oligonucleotide)-dependent production of SLS is accelerated when growth of the cells en tered stationary phase. W hether this enhanced pro duction is due to increased m essenger R N A synthesis or not is entirely unknown. M oreover, experim ental proof for or against induction of SLS messenger synthesis by the carrier is deficient, although R N A or oligonucleotide added as the carrier for SLS is often designated as "inducer" .
In order to address these questions, effects of in hibitors of nucleic acid synthesis have been tested, and influences of culture conditions such as carrier supplementation and medium shift have been ex amined, on macromolecular synthesis or SLS-producing capacity in hemolytic streptococci. In this re port, evidences are provided indicating that norflox acin blocks DN A synthesis and is inhibitory for SLS production in growing streptococci, and that SLS producing capacity (or SLS messenger) increasingly accumulates as the growth enters stationary phase, irrespective of presence or absence of the carrier sub stance.
Materials and Methods

Chemicals
Norfloxacin was generously provided by Kyorin Pharmaceutical Co. Ltd., Tokyo. Rifampicin was obtained from Daiichi Pharmaceutical C o., Tokyo, yeast RNA from Kohjin Co., Tokyo, RNase I core of yeast RNA from Sigma Chemical C o., St. Louis, and polyG was from Boehringer, M annheim.
Strain, m edia and culture technique
Strain Sa, an avirulent m utant of hemolytic strep tococci, was grown aerobically, but without shaking, in a peptone-m eat infusion broth at 37 °C. Growth of the bacteria was m onitored by measuring turbidity at 660 nm, with a Bausch & Lomb Spectronic 20A spectrophotom eter. Spent medium was prepared from an early stationary culture by centrifugation followed by filtration through a Millipore filter. For suspending washed resting streptococci, Bernheim er's basal medium [6] was used. W hen SLS pro duction was to be followed, yeast RN A (1% ) or the RNase core (0.5 mg/ml) was supplem ented. At inter vals, aliquot was withdrawn, rapidly filtered through a M illex-HA filter (M illipore C orp., Bedford) and hemolytic activity of the filtrate was determ ined as described previously [7, 8] .
D etermination o f nucleic acids and protein
A t the specified tim e, aliquot of streptococcal cul ture was rem oved into ice-cold 0.15 m saline, spun down and the cells were further washed once with the saline to remove residual medium which might interfere with subsequent chemical determ ination. A fter removing acid-soluble fraction, D N A , RNA and protein were determ ined as described elsewhere [9] -
Results
Effect o f norfloxacin on streptococcal macromolecular synthesis
In order to know target metabolism of norfloxacin in Gram -positive bacteria, exponentially growing streptococci were incubated with varying concentra tion of the drug for 60 min and increments in cell mass (as m easured by turbidity), D N A , RNA and protein were com pared. As presented in Table I , streptococcal D N A synthesis was considerably in hibited by 5 ng/ml of norfloxacin. Synthesis of bulk RN A was not particularly affected, but relative am ount of cell mass and protein was somewhat de creased under the condition. A t 10 to 20 ng/ml, in hibition of D N A synthesis was more than 90% and increm ent of cell mass, R N A and protein was also reduced significantly. Time course of macromolecular synthesis was next followed in streptococcal cul tures, in the presence and absence of 15 ng/ml of norfloxacin. Although the effect was pronounced on DNA synthesis, the drug evidently decreased rate and extent of synthesis of protein and, to a lesser degree, of RNA (data not shown).
Effect o f norfloxacin on SLS production
SLS yield in streptococcal culture was markedly reduced by 8 to 10 ng/ml of norfloxacin, which still allowed substantial growth of the bacteria (Fig. 1 ). On the other hand, production of the toxin by the resting cells suspended in BBM was practically insen sitive to the drug. In streptococcal culture, degree of inhibition of SLS production varied depending on growth phase: when added at early log phase, nor floxacin reduced the toxin yield, whereas addition of the drug at late log phase was ineffective (Fig.  2 A -C) . Pretreatm ent of the early log phase culture with 20 ng/ml of norfloxacin for 30 min did not affect initiation and rate of SLS production in the sub sequent culture. Prolonged pretreatm ent of the log phase culture caused growth inhibition, but allowed occurrence of the toxin synthesis after a considerable lag. Streptococci pretreated in BBM with 20 ng/ml of norfloxacin for 60 min grew normally and sufficiently produced SLS, after transfer into fresh culture medium containing RNase core.
Concentration (fjg/ml)
Sensitivity o f SLS synthesis to rifampicin
Insensitivity, to norfloxacin, of SLS production at the late stage of growth might indicate completion of SLS messenger synthesis, a possible target reaction, before entering stationary phase. To clarify this is sue, effect of rifampicin, a specific inhibitor of bacte rial RNA polymerase, was investigated on SLS pro duction in streptococcal culture. As seen in Fig. 2D , addition of 5 ng/m l °f rifampicin at late log phase completely blocked streptococcal growth and SLS production. M oreover, rifampicin effectively inhib ited SLS production, even after initiation of the toxin synthesis at stationary phase (Fig. 2E ) . These results dem onstrate that the observed norfloxacin resistance of SLS production at late growth stage is not due to sufficient accumulation of SLS messenger RNA.
Time of incubation ( h)
Fig. 2. Effects o f norfloxacin, rifampi cin and medium shift on streptococcal growth and SLS production. The bac teria were grown at 37 °C in peptonemeat infusion broth supplem ented with yeast R N A (A ) or the R N ase core (B ~ E ). Each culture was di vided into two and, at the time indi cated as zero, 15 ng/ml o f norfloxacin (A ~ C) or 5 ng/ml o f rifampicin (D , E) was added into one portion ( • ) . The other portion was kept unadded as control (O ). In the experim ent shown in F, log phase culture in peptone-m eat infusion broth was halved and one portion was spun down and suspended in a spent medium ( • ) . R N ase core was added to the suspen sion, as well as to the control (O ), and each suspension was incubated at 37 °C. Cellular growth ( ----------------) and SLS yield (-------------) was fol lowed as described in M aterials and M ethods. H U : hem olytic unit.
Relationship between growth phase and SLS p ro d u c tion
A lthough detectable am ount of SLS is synthesized even during log phase of growth, RNA-or oligo nucleotide-dependent production of the toxin is m anifested after cessation of the cellular growth, as exemplified in Fig. 2 . The capacity to produce oligonucleotide-SLS in BBM was also higher in the cells harvested from stationary phase culture than in the cocci collected at mid-log phase (Table II) . M oreover, when the stationary phase bacteria were transferred into fresh medium, the capacity signifi cantly decreased again upon resum ption of active growth. In addition, streptococci collected at log phase and suspended in spent medium produced, though at a reduced rate, a substantial am ount of SLS, without increase in cell mass (Fig. 2F) . Table II 
D evelopm ent o f SLS-producing capacity in the absence o f the carrier
Streptococci produce only trace am ount of SLS into the culture medium, unless specific carrier sub stance was added. The cells from the carrier-deficient culture still contain intracellular SLS [10], the pre cursor of the toxin, and excrete considerable amount of SLS, when washed and incubated in BBM sup plem ented with carrier oligonucleotides. Synthesis of bulk RNA as well as cellular growth does not occur in the washed cells and SLS production in the resting streptococcal system is insensitive to rifampicin [1] , These results indicate that SLS-producing capacity, possibly SLS messenger RN A , is endogenously formed without addition of the carrier. In order to ascertain this view, streptococci were grown respec tively in the presence and absence of carrier polyG (0.5 mg/ml), collected, washed and their capacity to produce polyG-SLS was com pared in BBM. SLS titer in each filtrate was 2.2 x 103 HU /m l in the polyGculture and less than 0.6 HU/ml in the control cul ture, whereas yield of the toxin in the resting strep tococcal system was 6.7 x 102 HU/ml in the cells harvested from the polyG culture and 5.8 x 102 HU/ ml in the control. Cellular growth was not particular ly affected by supplem entation of polyG. (W hen yeast RNA is added to culture medium, cellular growth is increased significantly and SLS-producing capacity of the resultant cells was 1.4-to 1.9-fold higher than that of the control. In this case, the RNA in the culture medium exerts its effect as a nutrient, rather than as a specific inducer.) In an additional experim ent, cells grown in the presence and absence of carrier oligonucleotides were transferred into the carrier-supplem ented broth and kinetics of SLS synthesis were followed. As to initiation and rate of the toxin production, no difference was found be tween the two second cultures.
Discussion
In E. coli, expression of several genes is, like D N A synthesis, sensitive to D N A gyrase inhibitor such as nalidixic acid [11] , Unavailability of gyrase inhibitor effective in Gram-positive pathogens has delayed elucidation of possible role of this enzyme in their DNA replication and gene expression. Present ex periments dem onstrate that streptococcal DN A synthesis and SLS production are inhibited by nor floxacin, a nalidixic acid analogue. A t lower concen tration, norfloxacin preferentially inhibits DNA re plication (but the inhibition is incom plete), whereas synthesis of RNA as well as of protein is affected by higher concentration of the drug. W hether the de creased synthesis of RN A and protein is due to inhib ition of DNA gyrase per se or to a secondary effect inherent in replication arrest is presently unknown. Inhibition of SLS synthesis is evident only when nor floxacin is added at early stage of streptococcal growth. Even at late log phase, however, addition of rifampicin or chloramphenicol suppresses the toxin production. Thus it seems less likely that the toxin synthesis is directly inhibited by this quinolone de rivative. Recently, Shen and Pernet have reported that norfloxacin inhibits gyrase action by binding to substrate D N A rather than to the enzyme molecule [12] . Norfloxacin pretreatm ent for 30 min at growing state or for 60 min at resting state did not affect sub sequent time course of SLS production. Probably, binding of the drug to D N A is not so strong as to prevent transcription of SLS gene.
SLS-producing capacity of streptococci is en hanced after the cells cease to grow and the toxin synthesis is blocked by addition of rifampicin at early stationary phase. The accumulation of SLS-produc ing capacity takes place w ithout addition of the car rier into the culture medium. A lthough its presence is essential for production of active SLS complex [3] , the carrier seems to be devoid of inducer activity for transcription of SLS gene. M oreover, streptococcal envelope probably prevents penetration of such carrier as polyG into the cytoplasm where mRNA synthesis takes place. It seems quite reasonable that rate of SLS synthesis increases upon cessation of streptococcal growth by exhaustion of nutrients in the medium. In tissue infected with the cocci, this regulatory mechanism may assure controlled supply of the nutrients for the bacteria, through timely lysis of the host cells by the toxin. In nutritionally rich environment which permits active growth, super fluous production of the hostdamaging toxin must be disadvantageous for the parasitic cocci as well.
